Life Expectancy in Developed Countries in the Absence of Smoking-Attributable Deaths

Brian Rostron, U.S. Food and Drug Administration (FDA)

This study uses a modified version of the recently proposed Preston-Glei-Wilmoth regression method to estimate smoking-attributable mortality and life expectancy in the absence of smoking-attributable deaths in 20 high-income countries. It finds that life expectancy at age 50 would be on average 2.2 years higher for males and 1.1 years higher for females in these countries in the absence of smoking-attributable deaths. Estimates of smoking-attributable mortality from this modified regression-based method are consistent with estimates from a modified version of the Peto-Lopez indirect method.